Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
(A joint stock limited company incorporated in the People's Republic of China with limited liability and carrying on
business in Hong Kong as 國控股份有限公司 )
(Stock Code: 01099)
ANNOUNCEMENT
PRINCIPAL FINANCIAL DATA OF
SINOPHARM (CNCM LTD)
FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019
This announcement is made pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and Part XIVA of the Securities and Futures Ordinance (Chapter 571, Laws of Hong Kong).
Reference is made to the overseas regulatory announcement of Sinopharm Group Co. Ltd. (the "Company") dated 23 October 2019 (the "Announcement") in relation to the third quarterly report for the nine months ended 30 September 2019 of China National Medicines Corporation Ltd. ("SINOPHARM (CNCM LTD)"), a subsidiary of the Company and whose A shares are listed on the Shanghai Stock Exchange (stock code: 600511).
The board of directors of the Company would like to draw the attention of its shareholders and the public investors to the following principal unaudited financial data of SINOPHARM (CNCM LTD) for the nine months ended 30 September 2019 as set out in the Announcement.
1
PRINCIPAL FINANCIAL DATA OF SINOPHARM (CNCM LTD)
Unit: Yuan | |||
Currency: RMB | |||
As at the end of this | As at the end of last | Increase/decrease at the | |
reporting period | year | end of this reporting | |
period as compared | |||
with the end of last year | |||
(%) | |||
Total assets | 24,264,517,325.33 | 21,509,768,350.39 | 12.81 |
Net assets attributable to | |||
shareholders of listed company | 10,000,623,286.48 | 9,232,394,076.27 | 8.32 |
From the beginning of | From the beginning of | Increase/decrease as | |
the year to the end of the | last year to the end of | compared with the same | |
reporting period | the same period of the | period of last year (%) | |
(January - September) | last year | ||
(January - September) | |||
Net cash flow arising from | |||
operating activities | 1,082,316,553.09 | 924,639,404.21 | 17.05 |
From the beginning of | From the beginning of | Increase/decrease as | |
the year to the end of the | last year to the end of | compared with the same | |
reporting period | the same period of the | period of last year (%) | |
(January - September) | last year | ||
(January - September) | |||
Operating income | 32,709,864,477.48 | 28,777,116,460.43 | 13.67 |
Net profit attributable to | |||
shareholders of the listed | |||
company | 1,071,317,614.60 | 950,487,969.99 | 12.71 |
Net profit attributable to | |||
shareholders of the listed | |||
company net of non-recurring | |||
gain or loss | 1,037,768,857.22 | 940,111,713.17 | 10.39 |
Weighted average return on net | decreased by 0.12 | ||
assets (%) | 11.16% | 11.28% | percentage point |
Basic earnings per share | |||
(RMB/Share) | 1.4015 | 1.2393 | 13.09 |
Diluted earnings per share | |||
(RMB/Share) | 1.4015 | 1.2393 | 13.09 |
2
By order of the Board
Sinopharm Group Co. Ltd.
Li Zhiming
Chairman
Shanghai, the PRC
23 October 2019
As at the date of this announcement, the executive directors of the Company are Mr. Li Zhiming, Mr. Yu Qingming and Mr. Liu Yong; the non-executive directors of the Company are Mr. Chen Qiyu, Mr. Ma Ping, Mr. Hu Jianwei, Mr. Deng Jindong, Mr. Wen Deyong, Ms. Guan Xiaohui and Ms. Dai Kun; and the independent non-executive directors of the Company are Mr. Yu Tze Shan Hailson, Mr. Tan Wee Seng, Mr. Liu Zhengdong, Mr. Zhuo Fumin and Mr. Chen Fangruo.
- The Company is registered as a non-Hong Kong company under the Hong Kong Companies Ordinance under its Chinese name and the English name "Sinopharm Group Co. Ltd.".
3
Attachments
- Original document
- Permalink
Disclaimer
Sinopharm Group Co. Ltd. published this content on 23 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 October 2019 10:54:12 UTC